Busheng Xue

Munich, BY 80804, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors.

Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors.

Journal: ImmunoTargets and therapy
Published: February 05, 2025

Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment.

Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment.

Journal: Frontiers in immunology
Published: March 18, 2024

Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.

Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.

Journal: Cancers
Published: May 28, 2023

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.

Journal: Cancers
Published: October 08, 2022

Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.

Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.

Journal: Cells
Published: September 30, 2021

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.

Journal: Cells
Published: July 05, 2021

MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.

MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.

Journal: Blood
Published: April 02, 2021

MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo.

MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo.

Journal: Cells
Published: May 31, 2020

Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.

Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer.

Journal: Epigenomics
Published: February 13, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026